• BV6 as a Selective IAP Antagonist: Experimental Workflows &

  2026-06-30

  BV6, a potent IAP antagonist from APExBIO, enables robust apoptosis induction and sensitization in cancer and endometriosis models. This guide delivers actionable protocols, advanced troubleshooting, and contextualizes BV6’s performance with leading research, empowering translational and experimental scientists to maximize assay success.

• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im

  2026-06-30

  This study introduces a novel gastric cancer assembloid model that integrates matched patient-derived tumor organoids with their native stromal cell subpopulations. The platform more accurately recapitulates tumor heterogeneity and reveals how stromal components modulate gene expression and drug response, advancing personalized cancer research.

• Protease Inhibitor Cocktail EDTA-Free: Precision in Protein

  2026-06-29

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) empowers researchers to preserve native protein states—crucial for phosphorylation and cation-sensitive assays—without risk of EDTA interference. Its broad-spectrum inhibition and DMSO formulation set a gold standard for reliable protein extraction in advanced molecular workflows.

• HyperScribe™ T7 High Yield RNA Synthesis Kit in CRISPR mRNA

  2026-06-29

  Discover how the HyperScribe T7 High Yield RNA Synthesis Kit empowers advanced gene-editing research, including CRISPR mRNA and gRNA production. This article uniquely explores protocol nuances, technical insights, and translational potential for oncology applications.

• Mebendazole Triggers PANoptosis in AML via TUBA1A Targeting

  2026-06-28

  This study demonstrates that mebendazole, a repurposed anthelmintic, induces ZBP1-mediated PANoptosis by targeting TUBA1A in acute myeloid leukemia (AML) cells, resulting in significant antileukemia activity. These findings highlight PANoptosis as a promising cell death pathway for AML therapy and illustrate the value of systematic drug repositioning approaches.

• RNAi Screen Reveals Vesicle-Mediated Host Factors in SARS-Co

  2026-06-27

  Kerr et al. present a comprehensive RNA interference screen identifying vesicular transport and exocytic pathways, particularly Rab11a-mediated cargo delivery, as critical host factors in SARS-CoV-2 release. Their findings suggest that selective inhibition of cyclin-dependent kinases, such as CDK9, can disrupt viral egress, opening new avenues for host-targeted antiviral strategies.

• Tomivosertib Suppresses Spontaneous Activity in Human DRG Ne

  2026-06-26

  The reference study provides the first direct evidence that inhibiting MNK signaling with tomivosertib rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion neurons from radiculopathy patients. This mechanistic insight advances the understanding of neuropathic pain and supports the translational potential of MNK inhibition as a therapeutic strategy.

• Structural Insights into PSS2 and SREBP Pathway Regulation

  2026-06-26

  This study delineates the structural and regulatory distinctions between human phosphatidylserine synthase 2 (PSS2) and its homolog PSS1, revealing how PSS2’s substrate specificity impacts lipid metabolism and SREBP signaling. The findings provide a mechanistic framework for understanding divergent roles of related enzymes in membrane biology and cholesterol homeostasis.

• AT13387 and the Evolving Biology of Apoptosis in Oncology

  2026-06-25

  This thought-leadership article explores the mechanistic and translational landscape of AT13387, a potent Hsp90 inhibitor, in the context of contemporary discoveries in programmed cell death. By connecting recent insights from virology (NINJ1-mediated secretion and apoptosis regulation) with cancer biology research, the article provides actionable guidance for translational investigators seeking to leverage Hsp90 chaperone inhibition for impactful experimental models and preclinical advancement. The discussion integrates AT13387's unique scaffold, high-affinity binding, and tumor-selective retention, positioning it as a next-generation tool for apoptosis induction and oncogenic signaling disruption.

• Nigericin Sodium Salt: Technical Guidance for Ion Transport

  2026-06-25

  Nigericin sodium salt is a potassium ionophore used to manipulate ion gradients and cytoplasmic pH across biological membranes, enabling precision in studies of ion transport, platelet aggregation, and Pb2+ handling. It is unsuitable for diagnostic or therapeutic use and is intended strictly for controlled laboratory research workflows.

• FerroOrange Fe²⁺ Fluorescent Probe: Precision Live-Cell Iron

  2026-06-24

  FerroOrange empowers researchers with rapid, specific detection of intracellular Fe²⁺ in living cells, streamlining iron metabolism and ferroptosis studies. Its superior compatibility with advanced imaging and cytometry platforms makes it an essential tool for unraveling neuronal iron dynamics and cellular stress responses.

• KNUCKLES Coordinates Hormonal Pathways for Floral Meristem T

  2026-06-23

  This study uncovers how the transcriptional repressor KNUCKLES (KNU) integrates auxin and cytokinin signaling to orchestrate the timely termination of the floral meristem in Arabidopsis. By directly repressing key genes for hormone transport and biosynthesis, KNU secures floral organ development, offering new mechanistic insight into plant developmental timing.

• Nuclear cGAS-TRIM41 Axis Suppresses L1 Retrotransposition vi

  2026-06-23

  This study demonstrates that nuclear cGAS restricts LINE-1 (L1) retrotransposition in human cells by promoting TRIM41-mediated ubiquitination and degradation of ORF2p, a key L1 protein. The findings uncover a DNA damage-responsive axis involving CHK2-dependent phosphorylation of cGAS, providing new insight into genome integrity maintenance and potential applications in aging and cancer research.

• TRPV1/TRPA1 Activation Drives TSLP via Ca2+/NFAT in Nasal Ep

  2026-06-22

  This study clarifies how TRPV1 and TRPA1 channel activation in human nasal epithelial cells stimulates the production of TSLP and other cytokines through a calcium-dependent NFAT pathway. These mechanistic insights reveal critical drivers of upper airway inflammation and inform future research on sensory ion channel modulation in epithelial biology.

• Praeruptorin A: Advanced Multi-Pathway Modulation in Disease

  2026-06-22

  Explore Praeruptorin A, an angular pyranocoumarin compound, as a versatile tool for dissecting iron metabolism, inflammation, and epithelial barrier repair. This article presents new translational insights and protocol guidance distinct from prior reviews.

408 records 10/28 page Previous Next First page 上5页 678910 下5页 Last page